| Literature DB >> 32284945 |
Michael S Rathleff1,2,3, Lukasz Winiarski3, Kasper Krommes2,4, Thomas Graven-Nielsen5, Per Hölmich4, Jens Lykkegard Olesen2,6, Sinéad Holden1,2, Kristian Thorborg4.
Abstract
BACKGROUND: Osgood-Schlatter disease (OSD) affects 1 in 10 adolescents. There is a lack of evidence-based interventions, and passive approaches (eg, rest and avoidance of painful activities) are often prescribed.Entities:
Keywords: Pediatrics; apophysitis; musculoskeletal; pain
Year: 2020 PMID: 32284945 PMCID: PMC7137138 DOI: 10.1177/2325967120911106
Source DB: PubMed Journal: Orthop J Sports Med ISSN: 2325-9671
Inclusion and Exclusion Criteria
| Inclusion criteria |
|
Pain localized at the tibial tuberosity that increased with palpation Pain on resisted isometric knee extension |
| Exclusion criteria |
|
Knee effusion Patellar instability Sinding-Larsen-Johansson syndrome Concomitant injury or pain in the hip, lumbar spine, or other structures of the knee (ie, tendinopathy, previous knee surgery, or patellofemoral pain) |
Building Blocks of the Intervention
| Block 1 (0-4 wk) | Block 2 (5-12 wk) | |
|---|---|---|
| Educational components |
Factors contributing to OSD Risk of OSD Loading and sport Rationale for treatment Increase/decrease of physical activity based on symptom response |
Importance of adherence Proper exercise form Monitoring and progressing |
| Modalities to gradually increase knee joint loads |
Activity modification Double-leg bridge Static holds of quadriceps muscle for 10 × 30 seconds (daily) |
Knee exercises (progressing from isometric holds to lunges) |
| Specific tools introduced |
Activity ladder Pain monitoring |
Activity ladder Pain monitoring Graded return to sport after step 8 has been reached on activity ladder |
OSD, Osgood-Schlatter disease.
Figure 1.Flowchart for recruitment of participants. The participants were recruited in parallel for both a study on Osgood-Schlatter disease (OSD) and patellofemoral pain (PFP).
Baseline Demographics (N = 51)
| Value | |
|---|---|
| Age, y | 12.7 ± 1.1 |
| Female sex, % | 51 |
| Weight, kg | 55.8 ± 10.1 |
| Height, cm | 165.5 ± 8.4 |
| BMI, median (IQR), kg/m2 | 20.2 (17.6-22.0) |
| Previously treated for knee pain, % | 35 |
| Difficulty with kneeling, % | 58 |
| Use of pain medication for knee pain, % | 12 |
| Physical activity, min, mean (95% CI) | |
| Sedentary | 344.2 (330.3-358.1) |
| Average light | 333.8 (315.7-351.9) |
| Average moderate | 115.5 (106.4-124.6) |
| Average vigorous | 133.1 (117.5-148.7) |
| Moderate to vigorous | 248.7 (225.1-272.2) |
| Reached WHO minimum physical activity recommendations per day, % | 92 |
Values are reported as mean ± SD unless otherwise indicated. BMI, body mass index; IQR, interquartile range; KOOS, Knee injury and Osteoarthritis Outcome Score; WHO, World Health Organization.
Based on participants reporting “moderate” or “severe” difficulties on question 5 of the KOOS Sport and Recreation subscale.
Based on available ActiGraph data from 47 adolescents with Osgood-Schlatter disease; there were missing data from 4 participants at baseline.
Figure 2.Proportion reporting a successful outcome (success defined as reporting “much improved” or “improved” on the global rating of change scale). Error bars indicate 95% CIs.
Figure 3.Self-reported outcomes from baseline to 12 months: Knee injury and Osteoarthritis Outcome Score (KOOS), health-related quality of life (QoL) as measured by the youth version of the EuroQol–5 Dimensions (EQ-5D-Y), and highest degree of pain during the past week (numeric rating scale [NRS]). ADL, Activities of Daily Living.
Sport Participation
| Before Intervention | After Intervention | |||||
|---|---|---|---|---|---|---|
| 4 wk | 8 wk | 12 wk | 26 wk | 52 wk | ||
| Participation in sport the previous month, number of positive responses/total responses | 51/51 | 7/49 | 4/44 | 7/43 | 28/42 | 27/39 |
| Current sport participation (training + competition per week), median (interquartile range), h/wk | 4 (3-5) | 1 (1-3) | 1.5 (1.0-2.5) | 1.5 (1.0-2.5) | 2 (1-3) | 3 (2-4) |
Compliance With Knee Exercises
| Days to Completion | Exercise Sessions in Total | Exercise Sessions per Week | Notes | |
|---|---|---|---|---|
| Block 1 | 4 wk for all | 18 (13-25) | 4.5 (3.3-6.3) | 13 did not report performing any of the exercises in block 1 |
| Exercise progression 1 | 33.5 (17-53) | 15 (8-24) | 3.4 (2.9-3.8) | 11 did not report performing any of the exercises in progression 1 |
| Exercise progression 2 | 25 (11-34) | 11 (5-15) | 3.5 (3.1-3.9) | 22 did not report performing any of the exercises in progression 2 |
| Exercise progression 3 | 19 (15-27) | 9.5 (7-12) | 3.4 (3.2-3.6) | Only 12/51 reached progression 3 (as documented by their training diary) |
Values are reported as median (interquartile range). Based on data from 38 training diaries.
Use of Painkillers and Additional Treatments
| No. of Participants | |
|---|---|
| 4 wk (n = 48) | |
| Physical therapy | 2 |
| Treatment (type not specified) | 2 |
| Pain medication | 3 |
| 8 wk (n = 44) | |
| Physical therapy | 1 |
| Treatment (type not specified) | 3 |
| Pain medication | 1 |
| 12 wk (n = 43) | |
| Treatment (type not specified) | 2 |
| Pain medication | 0 |
| 26 wk (n = 42) | |
| Physical therapy | 3 |
| Treatment (type not specified) | 3 |
| Pain medication | 0 |
| 52 wk (n = 41) | |
| Physical therapy | 2 |
| Body Self Development System | 1 |
| Craniosacral therapy | 1 |
| Pain medication | 0 |
Sample sizes refer to the number of participants who responded at each time point.